NCT02646852View on ClinicalTrials.gov

A Phase I Study of PLX038 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 28, 2023

Study Completion Date

July 31, 2023

Conditions

TumorsNeoplasmsCancer

Interventions

DRUG

PLX038

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

ProLynx LLC

INDUSTRY

NCT02646852 - A Phase I Study of PLX038 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter